Intervention Review

Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease

  1. van Hilten1,*,
  2. Claudia C Ramaker1,
  3. Rebecca Stowe2,
  4. Natalie Ives2

Editorial Group: Cochrane Movement Disorders Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 19 AUG 2007

DOI: 10.1002/14651858.CD003634.pub2


How to Cite

van Hilten, Ramaker CC, Stowe R, Ives N. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003634. DOI: 10.1002/14651858.CD003634.pub2.

Author Information

  1. 1

    Leiden University of Medical Center, Department of Neurology, Leiden, Netherlands

  2. 2

    University of Birmingham, University of Birmingham Clinical Trials Unit, Birmingham, UK

*van Hilten, Department of Neurology, Leiden University of Medical Center, Albinusdreef 2, Leiden, 2333 ZA, Netherlands. j.j.van_Hilten@lumc.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

  1. Current Version

    Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease

    van Hilten, Claudia C Ramaker, Rebecca Stowe and Natalie Ives

    Article first published online: 17 OCT 2007 | DOI: 10.1002/14651858.CD003634.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease

    CC Ramaker and JJ van Hilten

    Article first published online: 22 APR 2002 | DOI: 10.1002/14651858.CD003634